ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: Results from an Intergruppo Italiano Linfomi randomized study

V. Pavone, U. Ricardi, S. Luminari, P. Gobbi, M. Federico, L. Baldini, E. Iannitto, G. Ucci, L. Marcheselli, L. Orsucci, E. Angelucci, M. Liberati, P. Gavarotti, A. Levis

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: Results from an Intergruppo Italiano Linfomi randomized study'. Together they form a unique fingerprint.

Medicine & Life Sciences